Innovative peptides as targeted therapies for oncology
PEP-Therapy has raised $1.9M in total funding. The most recent round was Series A. The last funding was announced in July 2021.
PEP-Therapy's investors include Bpifrance, Seventure Partners, Italian Angels for Growth, Anaxago, Les Business Angels des Grandes Écoles.
PEP-Therapy is headquartered in Évry, France.
Innovative peptides as targeted therapies for oncology
PEP-Therapy is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"PEP-Therapy — Funding & Investors." VCBacked, July 19, 2021, https://www.vcbacked.co/company/pep-therapy. Accessed July 20, 2026.
VCBacked. (2021). PEP-Therapy — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/pep-therapy
{{cite web |title=PEP-Therapy — Funding & Investors |url=https://www.vcbacked.co/company/pep-therapy |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated